FDA Panel Revisits Avandia, But Likely Too Late For Diabetes Drug
"They got it right for what they were allowed to say," said Marciniak. Some Record documents were redacted, he said, and
fda panel revisits avandia likely late diabetes drug get right allow say marciniak record document redact say